申请人:VERNALIS RES LTD
                            
                            
                                公开号:WO2001007022A2
                            
                            
                                公开(公告)日:2001-02-01
                            
                            Use of a compound of formula (I) wherein R1 is aryl; and R2 is hydrogen or alkyl; or a pharmaceutically acceptable salt or prodrug thereof in the manufacture of a medicament for neuroprotection in a subject or for the treatment of cerebral ischaemia, central nervous system injury or eye diseases.